Care Start Malaria™ | VIKIA Malaria Ag Pf/Pan™ | |||
---|---|---|---|---|
Pf or mixed | non-Pf | Pf or mixed | non-Pf | |
Lyon | ||||
Sensitivity % (95% CI) | 98.0 | 60.0 | ||
(87.8–99.9) | (32.9–82.5) | |||
Specificity % (95% CI) | 93.1 | 100.0 | ||
(85.8–96.9) | (96.6–100.0) | |||
PPV % (95% CI) | 87.3 | 100.0 | ||
(74.9–94.3) | (62.9–100.0) | |||
NPV % (95% CI) | 98.9 | 95.7 | ||
(93.4–99.9) | (90.6–98.3) | |||
Bamako | ||||
Sensitivity % (95% CI) | 96.2 | 60.0 | 94.6 | 100 |
(90.8–98.6) | (17.0–92.7) | (88.8–97.6) | (46.3–100.0) | |
Specificity % (95% CI) | 97.7 | 99.4 | 98.0 | 99.2 |
(96.0–98.7) | (98.5–99.8) | (96.4–98.9) | (98.1–99.7) | |
PPV % (95% CI) | 89.9 | 42.9 | 91.1 | 45.5 |
(83.4–94.2) | (11.8–79.8) | (84.7–95.1) | (18.1–75.4) | |
NPV % (95% CI) | 99.1 | 99.7 | 98.8 | 100.0 |
(97.9–99.7) | (98.9–100.0) | (97.5–99.5) | (99.3–100.0) |